Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 20 May 2025

Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units

in Pharmacoepidemiology

Rafael Nogueira de Souza
Marília Berlofa Visacri
Fabiana Bragança Albanese Trotta
Deise de Souza Ventura
Mauricio Wesley Perroud
Patrícia Moriel

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1514942

1,115 views

Original Research

Published on 20 May 2025

Enhancing medication appropriateness: Insights from the STOPP (Screening Tool of Older Persons’ Prescriptions) criteria version 3 on prescribing practices among the older adults in Pakistan

in Pharmacoepidemiology

Halima Sadia
Safila Naveed
Hina Rehman
Shazia Jamshed
Huma Dilshad

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551819

929 views

Original Research

Published on 16 May 2025

Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database

in Pharmacoepidemiology

Bingqing Wang
Kaidi Zhao
Ningyi Xian
Landong Ren
Jiashu Liu
Chen Tu
Dewu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1497708

1,382 views

Original Research

Published on 14 May 2025

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database

in Pharmacoepidemiology

Yuan-Yuan Wu
Qiong-Lian Huang
Zhan-Yang Luo
Xiao-Yun Song
You-Yang Shi
Jin-Zhou Zheng
Sheng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529342

1,358 views

Original Research

Published on 13 May 2025

Time-dependent impact of immunosuppressant regimens on cardiovascular outcomes in kidney transplant recipients: a nationwide cohort study

in Pharmacoepidemiology

Jinhyun Park
Wonhui Choi
Jinseub Hwang
Young-Mi Ah
Byung Ha Chung
Yun-Kyoung Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540576

952 views

Original Research

Published on 12 May 2025

Drug stockpiling behavior and its impact on anxiety among the general public in the early stage after the lifting of China’s Zero-COVID policy: results from a web-based survey

in Pharmacoepidemiology

Yu Huang
Shuiyang Xu
Xiang Zhao
Lei Wang
Qiaohong Lv
Suxian Wu
Qingqing Wu
Xuehai Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1524068

738 views

Original Research

Published on 09 May 2025

Construction and validation of a meropenem-induced liver injury risk prediction model: a multicenter case-control study

in Pharmacoepidemiology

Yan He
Hongqin Ke
Jianyong Zhu
Xin Yuan
Hongliang Li
Wenwen Wu
Shuman Yang
Huibin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1542554

1,072 views

Original Research

Published on 06 May 2025

Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure: a retrospective examination of real-world cohort

in Pharmacoepidemiology

Aseel Sukik
Ahmed Tarek Aboughalia
Abdul Haseeb Said Wali
Amro Al Radaideh
Omar Mohamed Elsayed
Mohammed A. Amer
Joud Said Abuodeh
Oyelola A. Adegboye
AbdelNaser Elzouki
Mohammed Ibn-Mas‘ud Danjuma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1526112

1,293 views

Original Research

Published on 06 May 2025

Adherence and persistence with istradefylline treatment in patients with Parkinson’s disease in the United States

in Pharmacoepidemiology

Reversa Joseph
Joyce Qian
Hannah Cummings
Yen-Hua Chen
Shubham Tewari
Michael Soileau

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548631

1,574 views

Original Research

Published on 02 May 2025

An in-depth exploration of the association between olanzapine, quetiapine and acute pancreatitis based on real-world datasets and network toxicology analysis

in Pharmacoepidemiology

Shuang Wang
Liying Song
Yuanjie Sun
Haonan Zhou
Jia Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529416

2,192 views

Original Research

Published on 02 May 2025

Comprehensive analysis of adverse events associated with vortioxetine using the FDA adverse event reporting system

in Pharmacoepidemiology

Liangxia Li
Qianqian Xu
Liangfang Pang
Yarui Liu
Yuanyuan Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519865

1,865 views

Original Research

Published on 30 Apr 2025

Post-marketing safety of anakinra and canakinumab: a real-world pharmacovigilance study based on FDA adverse event reporting system

in Pharmacoepidemiology

Hao Liu
Wei Yan
Jinsong Li
Dezhi Yan
Di Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1483669

1,872 views

Original Research

Published on 30 Apr 2025

Drug-associated infections and infestations in older adults with tumor necrosis factor-alpha inhibitors: a real-world retrospective and pharmacovigilance study

in Pharmacoepidemiology

Xihui Yu
Jiahong Zhong
Xuemei Zhuang
Zhuomiao Lin
Hongbo Fu
Yaofeng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533902

2,493 views

Original Research

Published on 28 Apr 2025

Charting the COVID-19 vaccination journey in Saudi Arabia: Insights into post-vaccination adverse effects and immunization dynamics

in Pharmacoepidemiology

Gehad M. Subaiea
Nawaf Alkhateeb
Faisal Sahman
Abdulrahman Alsudayri
Abdulkarim M. Almudayni
Hamoud Alrashidi
Abdulrahman M Alshammari
Abdulwahab Alamri
Sultan Almuntashiri
Arshad Hussain

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561410

901 views

Original Research

Published on 28 Apr 2025

Prescribing characteristics and guideline concordance of antihypertensive western and Chinese patent medicine in Internet hospitals in China: a cross-sectional study

in Pharmacoepidemiology

Tiantian Zhou
Xing Liao
Jiaxin Zuo
Fang Han
Ruogu Meng
Lin Zhuo
Guozhen Liu
Jing Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1580787

1,151 views

Original Research

Published on 28 Apr 2025

Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases

in Pharmacoepidemiology

Tao Wang
Zhiwei Cui
Yingyong Ou
Siyu Lou
Huayou Chen
Chengyu Zhu
Linmei Zhou
Fan Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1530697

2,086 views